Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I called ITOR/GHS and Oncolix had tested Prolanta initially on a lot more than 3 patients. They only had enough of the drug to complete 3 patients. Those 15 that are lined up are probably the ones who they weren't able to get enough of the drug for.
IMO
There are lots of false claims being passed around on this board that could use a good explanation. An explanation backed by credible sources. Welcome to the AEPP board!!!
You know you're in a good OTC when the naysayers have to fabricate information. Sure makes me feel confident. Oncolix is bulletproof compared to most.
Why keep trying to trash a company that is attempting to fund and complete clinical trials for women in need of these treatments? They are obviously going to burn through cash as they do not have a drug on the market generating any revenue. The trials and manufacturing of Prolanta certainly aren't free or cheap for that matter. Are you expecting them to be able to operate for free? How can they mitigate these costs to prevent burning through cash like it's 'water'? Id love your expert analysis.
Oncolix is a company that has been in existence for 10+ years developing and testing a drug that has been researched and studied dating back to 1999. This isn't some joke. Oncolix obviously needs cash in order to complete what they set out to do. Going public is the fastest way to obtain the much needed funding to continue operations and not let the past 18 years go to waste. If successful, they will be doing a huge service to society and helping thousands to millions of cancer patients worldwide.
It's one thing to criticize one of these crypto stocks or some other scammy worthless OTC, but to do it to a legitimate company trying to benefit society and save lives is just shameful.
I'm rooting for Oncolix to not only succeed from an investor standpoint, but also from a human standpoint. Prolanta has the potential to really help a lot of people.
Since their operations clearly cost money and they don't have a way to currently generate revenue, what are they supposed to do? Close up shop?
Thoughts?
Everyone keep up the great work! All the posting back and forth has us on the 'Most Active' list and hopefully soon we will be on the 'Breakout Board' list!
Loving the AEPP/Oncolix discussion!
You got it.
See that's why they need you on board to steer them in the right direction with your insight and ideas. You could make sure they hire the right personnel and get the best financing. Then we all make tons of money all due to the great and glorious savior known as 'Namtae'!
I'm going to email Redman right now to inform him about the all-star pharmaceutical savant lurking on the ihub board. I'm sure he will be thrilled with delight!
Yes business is slow, welcome to the world of a clinical stage biopharma that has already burned through $15m-$20m in VC money.
Could they have tried to go through more rounds of VC funding and the whole process of presenting to investors in the hopes of getting more investors on board? Yes they could. But that is a long drawn out process. They are in the midst of phase I trials and need capital now. The decision was made to go public and secure an equity investment in the fastest manner possible to get the "slow business" back on track.
They don't have time to waste as they need capital to manufacture more Prolanta to complete these trials asap.
I know you must have been a great CEO for a pharmaceutical company at some point, because you seem to have all the answers. Have you thought about contacting Michael Redman to see if he would bring you on board as an advisor/consultant? Because his 30+ years of experience in the industry doesn't seem to be doing him any good by your standards.
Oncolix could really use your expertise as a serious asset. I'm being dead serious too.
Oh yeah and why is that? Why don't you call GHS/ITOR and ask for Lisa Johnson and find out whether or not I spoke to her the other day? Instead of just popping off without even knowing what you're talking about.
When the positives are completely ignored all credibility goes out the window. The people who have the most credibility are the ones who truly playing devil's advocate and can see things from both sides.
This just confirms my point that I made the other day about the one-sided argument to the negative.
You've got to be kidding me?? I've been a finance manager and worked with loan officers and the only way you can get business credit is having a revenue generating business. A clinical stage biopharma has no way to produce revenue and therefore has no way to pay back a loan and build credit. What bank is going to lend money to a company with income?This is the struggle that almost every clinical stage company has to endure. They need venture capital, private offerings, or what you refer to as toxic financing to conduct business. Toxic financiers are the only ones willing to take on the risk of lending money to non revenue generating biopharma's.
The fact that they were able to obtain as much VC money and donations for the past 10+ years is pretty telling. Most small clinical stage biopharma's are lucky if they can even raise $1m. Oncolix has raised $15m-$20m.
Well I hate to say it but your opinions wrong why don't you try making some phone calls for yourself?
I can attest to all of this being false, especially after personally talking to GHS/ITOR.
Good try though.
Wow we just had a nice increase in volume.
Oh so you called them as well?
So we have a small pharmaceutical company backed by some pretty big investors, that's been forced to go public in order to raise more funds to continue manufacturing and testing Prolanta, a drug that is showing efficacy and no adverse effects. And it's only trading at .05-.06!? Redman could've easily just sold this whole operation over to a larger pharmaceutical company. I mean, he's been sitting on this company for 10+ years, but obviously he and his investors are holding on to Oncolix/Prolanta for a reason.
What absolute gift we have here to be able to own a piece of this at such low prices.
Patience and patients will be rewarded here.
IMO
You guys can take this for what it's worth, but I just got off the phone with ITOR/GHS, where the trials are being conducted. Here its the gist of my phone call with them:
I had asked why the trials had stopped, and was told that it was due to Prolanta being in short supply. They had a lot more than 3 patients enrolled and tested on, but were only able to complete 3, because of the supply shortage. The woman on the phone told me that every single patient had tolerated the drug well with little to no side effects. I asked her about the efficacy of the drug, and she told me that every patient that was tested had progressed with their conditions and it's a shame that they had to stop the trials.
As you know, the trials were last updated back in April and that is also around the time that Oncolix had decided to go public. So if you put two and two together, they are obviously doing this in order to continue funding their trials and manufacturing of Prolanta.
All in all, I would say it was a positive phone call and is in line with a lot of what we already knew. It sure made me feel good to hear her say that ALL of the patients were progressing.
Well as you know the trials are required by law to be updated at least once every 12 months. So we know that we are closing in on that time frame requirent and will have results/updates sooner rather than later.
I appreciate the points that you bring to the table, as both sides of the argument are needed. The only thing that makes it tough for me is how one-sided your argument is to the negative.
There aren't any catalysts you feel can propel the PPS?
It seems like anything short of curing cancer will not suffice, for you.
I just saw DOLV run from .03 to .15 by announcing a new ticker. IPIX ran from .15 to 4.93 on positive phase I results.
Even with a fully diluted OS, Oncolix will still have a great share structure. Most of the OTC is full of diluted pigs, so that is a huge positive.
There are lots of positives here, but for some reason they don't matter in your book.
Ticker change is important as it will bring more validity to the merger and more eyes here once complete. This company has the backing of some big players like Ernest Mario Glaxo. Oncolix has 34 patents, which is no small feat, especially in OTC land. Acquiring more drugs that are trial ready to add to the pipeline is important so that investors won't feel like we have all of our eggs in the basket of Prolanta. The list of positives is even more extensive than this, but these are just a few examples.
As you know, you can literally go into ANY OTC stock and dig up all the same dirt you're throwing up about AEPP. It's all pretty standard stuff. What is hard to find is any of the positive stuff that Oncolix has in any of the other OTC stocks, which for some reason you refuse to recognize as being even remotely significant.
You literally have nothing good to say about this company?
I mean it's trading on the OTC at .05!? If we wanted perfect pharmas to invest in, we would be buying companies on the Nasdaq at $50-$100 per share.
We KNOW there are flaws here, but we also KNOW that there are some positives here.
What does Oncolix need to do to get YOUR seal of approval?
Just curious.
All I'm saying is I like the potential catalysts here and when compared to other companies, I know this can run too just as they have. Obviously there is no way to predict what's going to happen. If we were able to do that we would all be filthy rich. There is no perfect OTC stock and you can dig up dirt on any one of them and come up with plenty of reasons why they will fail. There's a reason they are in the OTC in the first place.
I spend my time on stocks I personally feel have the best odds and potential of succeeding. I really don't see much out there right now, that hasn't already run, that has as much to offer as Oncolix.
I'm not trying to rush things here either. I'm willing to wait and see how things unfold and will continue to be patient.
OTC catalysts don't have to be amazing to cause a stock to run. Look at OWC, it ran to $3.23 on practically nothing. Oncolix has quite a bit more going for it and anything remotely positive from phase I trials can send it parabolic like what happened to Innovation Pharma, which ran to $4.93. Even with a fully diluted OS from everything contained in the S1, Oncolix still has the potential to make a comparable run to those two companies.
IMO
Great post. Deserves a sticky.
This is a great list of catalysts if you ask me. OWC's major catalyst that sent it from .002 to $3.23 was some preliminary data on a medical marijuana psoriasis cream and a ton of investor hype. Keep in mind it's just a treatment for a condition which there is a lot of competition for from companies like Gold Bond.
I like Oncolix' catalysts and what the potential PPS is based on comparing what caused other tickers to run. Innovation pharmaceuticals ran up to $4.93 after positive phase I safety results and some evidence of efficacy for their ovarian cancer drug. Prolanta has that type of potential with its trials.
Time will ultimately reveal all.
Back when the merger was first found out about a similar thing happened with the company officers. It went from Brian Kistler and Nigel Bosworth to Michael Redman and Donald Payne and then switched back and then switched again to what it is now.
Their OTC Markets page has been doing funny things right along through this whole merger process.
There's something glitchy going on with the OTC Markets AEPP page. I've seen the OS figure jump back and forth between 93m and 103m several times now.
I must say you have made some very compelling arguments. Especially that one time you described with verifiable proof and irrefutable evidence that AEPP is without out a doubt a scam. Here's the quote that really hit it home for me:
"AEPP IS PAPER SCAM STOCK. STRONG SELL"
If you people can't see where he's coming from with that statement, then you just aren't seeing his DD and I have no idea why because it's pretty clear and obvious. He has spent a lot of time digging up the dirt on Oncolix for all of us.
IMO
Considering all of the insiders have restricted shares, I fail to see how anyone from Oncolix would benefit from a "fake" merger pump when they can't even cash in on it. The only people who benefited from selling shares between .165-.195 would be us retail investors. So what motivation does Oncolix have to pump this up at this stage in the game? Just for amusement?
It would make sense for them to pump this up when their restricted period has expired so they can dump everything they have at higher prices and make out like bandits. Until then, Oncolix has no way to benefit from this supposed "scam".
This is all common sense.
IMO
It took no less than 30-60 seconds of DD to find several successful and legitimate companies who have worked with Small Cap Voice. There are stocks that they've helped that are on the OTCBB and NYSE/AMEX exchanges.
I'm still struggling to find the negative in using Small Cap Voice as a means to raise company awareness. Help me understand the feelings you have in regards to this.
Just copy and paste why I said. Tell him we're using the numbers from the cap chart.
I don't see how it's possible. I'm honestly surprised by that email response. I don't see how they can get to those figures without raising the AS to over 4 billion. It says right in the 8K they are only raising it to 500m, so how is it physically possible for them to come up with 166m shares post split? Even if you reverse split 25:1 a maxed out AS of 500m shares, you would end up with only 20m shares.
There's either a piece of information that we're missing or McPherson isn't explaining things correctly.
I really have no idea at this point. But the wording they used in the MOU is 'members interests' and that's terminology used in regards to a private LLC. It looks clearly as if they are reverse splitting those members interests of around 4 billion down to a figure of 166 million.
So I really don't know what to say.
If you can see this 'scam' then the SEC would definitely be able to see this 'scam'. So that must mean the SEC is in it on it and letting Oncolix get away with it?
That would also mean that ITOR and the Greenville Health System who only deal with reputable biopharma's is also in on it?
I would love to hear your explanation for this conspiracy theory.
TIA
You really don't know what that means? I thought that was common knowledge.
JK LOL
Looks like there's also been a delay on credible sources that backup any of this. When will that delay come to an end?
TIA
$12,000 is a small price to pay for some marketing and media coverage. I suppose you think they should be doing it for free?
'Zero' is giving a little too much credit and awfully generous of you.
This should go under the category of off topic. This isn't even opinion based. This is a mess of lies which can easily be debunked by a quick Google search.
Obviously we don't know the extent of efficacy Prolanta has produced because there hasn't been any clinical data released to the public as of yet. But we do know insofar that at the lowest dose, there is some sort of efficacy and little to no adverse reactions in the 3 patients that have been tested.
That's more positive than negative at this point and it's certainly not enough to draw a conclusion of Prolanta being a 'failure'. We don't have enough information to draw any conclusions, but there is potential and in time it will be uncovered whether it's positive, negative, or neutral.
Wow i didn't realize it would be so low. That's a great deal compared to what most companies have. Thank you for the great DD and bringing that information to our attention. Things just continue to look better and better.
GO ONCX/OCLX/ONLX!!!
Nope and neither am I. That was just an ongoing theory from the peanut galley around here. The ol' Friday paint job theory. You're right though, all of the price action leading up to these significant catalysts are meaningless.